The current status of interferonα in haemic malignancy
- 1 September 1990
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 4 (3) , 175-180
- https://doi.org/10.1016/0268-960x(90)90045-t
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- ANTIBODIES TO LYMPHOBLASTOID INTERFERONThe Lancet, 1989
- Recombinant human interferon (IFN) alpha‐2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti‐interferon antibodiesBritish Journal of Haematology, 1989
- Therapy for Neutropenia in Hairy Cell Leukemia with Recombinant Human Granulocyte Colony-Stimulating FactorAnnals of Internal Medicine, 1988
- Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationBlood, 1988
- Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon AntibodiesNew England Journal of Medicine, 1988
- Therapy of chronic myelogenous leukemia with recombinant interferon- gammaBlood, 1987
- Clinical investigation of human alpha interferon in chronic myelogenous leukemiaBlood, 1987
- Interferon nomenclatureNature, 1980
- Induction and kinetics of natural killer cells in humans following interferon therapyNature, 1979
- Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol)Blood, 1979